TGF‐β1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease

Alzheimer's disease (AD) is a neurodegenerative disorder that affects more than 37 million people worldwide. Current drugs for AD are only symptomatic, but do not interfere with the underlying pathogenic mechanisms of the disease. AD is characterized by the presence of ß‐amyloid (Aβ) plaques, n...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:CNS Neurosci Ther
Asıl Yazarlar: Caraci, Filippo, Battaglia, Giuseppe, Bruno, Valeria, Bosco, Paolo, Carbonaro, Viviana, Giuffrida, Maria Laura, Drago, Filippo, Sortino, Maria Angela, Nicoletti, Ferdinando, Copani, Agata
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Publishing Ltd 2009
Konular:
Reviews
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493850/
https://ncbi.nlm.nih.gov/pubmed/19925479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2009.00115.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller